Contact Person
    Sophie Labrosse

    Project Manager
    Email: sol@www.chfest.com
    Phone: (M) +45 24 60 00 46
    Linkedin

    MVA R&D Network webinar – June 2020

    Welcome to the first webinar for the Medicon Valley Alliance R&D Network!

     

    Connecting the R&D of auto-immune disease therapies – starting from the type 1 diabetes perspective

    Over a long period of time, the Øresund region has built up strong and internationally recognised competencies within the fields of screening, genetics and immunology in type 1 diabetes and other autoimmune diseases. The coupling between type 1 diabetes and other autoimmune diseases contains an immense potential for the development of new drugs and therapies. This meeting will give an insight in some of the coordinating and individual R&D efforts that are existing in Medicon Valley today in the field of type 1 diabetes and the bridges to other auto-immune diseases. 

    Until we can meet in large groups, we have decided to bring the possibility to share experiences in a shorter webinar format in stead of our regular networking meetings.

    Date:

    18 June, 2020

    Time:

    11:00-12:15

    Host:

    MVA R&D Network

    Venue:

    Online – all registered participants will receive a link 2 days before the event

     

    Sign up

    The MVA R&D Network
    The Medicon Valley Alliance R&D Network is a professional and social network for C-level R&D executives (CSOs, CMOs, VPs), university professors and PIs, and top-level managers in the hospital sector.The network focuses on sharing best practice and experiences, as well as discussing current challenges for industry-academia collaboration and the commercialization of R&D in the Medicon Valley region, such as how we can strengthen collaboration and knowledge-sharing between academia and industry to stimulate start-up, scale-up, commercialization and growth and wat is required to turn great science into successful innovations.

    Joining the network is free of charge but is limited to Medicon Valley Alliance members. However, non-member organizations and companies are welcome to attend one network event to evaluate if joining the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically allow you to join the medtech network.

    Program

    Moderator: Sophie Labrosse, Medicon Valley Alliance

    10.50-11.00

    Webinar platform open for connecting participants

    11.00-11.05

    Welcome by Petter Hartman, CEO, Medicon Valley Alliance

    11.05-11.20

    Joining forces for novel treatments for type 1 diabetes
    Finn Kristensen, Project Manager DiaUnion, Medicon Valley Alliance 

    11.20-11.35

    Steno Diabetes Centres – a Danish Public Private Partnership 
    Jannik Hilsted, SVP Patient Care and Chief Medical Officer, Novo Nordisk Fonden 

    11:35-11:50

    Dissecting the etiology of type 1 diabetes and associated celiac and thyroid diseases
    Åke Lernmark, Senior Professor and Principal Investigator, Diabetes and Celiac Unit at Lund University

    11.50-12.00

    The state of R&D in Medicon Valley – 2 pitches 

    Adam Steensberg, EVP R&D and Chief Medical Officer, Zealand Pharma

    Jan Alenfall, CEO, Follicum

    12:00-12:10

    Testimonial

    Jeannette Söderberg, Associate Director European Research, JDRF

    12.10-12.15

    Final Q&A and conclusions

    Deadline for registration is June 15, 2020 at noon.

    For more information please contact Sophie Labrosse at sol@www.chfest.com